At the news
? NEUTRALIMPACT 4/10 CLUSTER filed Mar 2, 2026 at 17:32 ET
Seven insiders at Madrigal Pharmaceuticals, including the CEO, CFO, and other C-suite executives, conducted open-market sales and stock awards within a 7-day window. The total value of open-market sales was approximately $2.37 million, representing modest insider selling activity at a company with a $10.1 billion market cap.
- CEO William Sibold sold $718,316 worth of shares in open-market transactions on March 6, 2026.
- CFO Mardi Dier sold $505,389 worth of shares on March 2, 2026.
- Four other C-suite executives sold shares totaling $1.15 million on March 6.
- Five insiders received non-cash stock awards totaling 27,375 shares on March 4, 2026.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access